Ainos Warrants (AIMDW)

• Market cap: $3.59M
• 1 day: 0.00%
• 5 days: 73.67%
• 1 month: 91.37%
• 3 months: 60.31%
• 6 months: 307.83%
• Year to date: 316.80%
• 1 year: 362.08%
• 5 years: -72.21%
• 10 years: -72.21%
• Sector: Healthcare
• Industry: Medical Devices

About: Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Employees: 44

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

57% more capital invested

Capital invested by funds: $19.9K [Q4 2024] → $31.3K (+$11.4K) [Q1 2025]

0.13% less ownership

Funds ownership: 1.41% [Q4 2024] → 1.28% (-0.13%) [Q1 2025]

13% less funds holding

Funds holding: 8 [Q4 2024] → 7 (-1) [Q1 2025]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3